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Background: The aim of this study is to develop a prognostic nomogram for patients with adenocarcinoma of
esophagogastric junction and compare its predictive accuracy with the traditional tumor-node-metastasis (TNM)
malignant staging system.
Methods: Patients from the Surveillance, Epidemiology, and End Results Program (from 1988 to 2011) and the First
Affiliated Hospital of Xi’an Jiaotong University (from 2005 to 2010) were collected retrospectively. Preselected
multiple potential interactions were tested irrespective of significance as nomogram parameters. And the Harrell’s
C-index was used to estimate the accuracy of the nomogram system. Model validation was performed using boot-
strap to quantify our modeling strategy.
Results: In our study, six clinical associated factors (age, sex, depth of invasion, metastasized lymph nodes,
examined lymph nodes, histological grade) were evaluated in the nomogram. In the training set, the nomogram
exhibited superior discrimination power compared with the American Joint Committee on Cancer (AJCC) TNM
classification (Harrell’s C-index, 0.69 and 0.63, respectively). Calibration of the nomogram predicted survival was simi-
lar to the actual overall survival. In the validation set, the discrimination of nomogram was also better than the AJCC
TNM staging system (C-index, 0.75 and 0.65, respectively), and the calibration of nomogram predicted survival was
within a 10 % margin of actual overall survival.
Conclusions: Based on the patients with adenocarcinoma of esophagogastric junction from a Western and an
Eastern database, the nomogram provided significantly improved discrimination than the traditional AJCC TNM
classification and also provided an accurate individualized prediction of the survival.
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In Western countries, there has been a dramatic increase
in the incidence of adenocarcinomas of the esophago-
gastric junction (AEG). But in Eastern countries, they
have not experienced such an increase [1–4]. The defin-
ition of AEG was confused until the recent Union for
International Cancer Control (UICC) and American Joint
Committee on Cancer (AJCC) tumor-node-metastasis
(TNM) classification of malignant tumors had been pub-
lished. Based on UICC classification, a tumor with an epi-
center within 5 cm of the esophagogastric junction (EGJ)
and extension into the esophagus is classified and staged
according to the esophageal scheme; while tumors with an* Correspondence: dangchengxue@mail.xjtu.edu.cn; dr.syc@163.com
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creativecommons.org/publicdomain/zero/1.0/epicenter greater than 5 cm from the EGJ or those within
5 cm of the EGJ without extension into the esophagus
were classified and staged according to the gastric carcin-
oma scheme [5]. There are many surgical approaches for
AEG as a junctional cancer. Previously, some surgeons
treat it like distal esophageal cancer and some others are
more likely to treat it like proximal gastric cancer. This
also means that they treat AEG according to different ap-
proaches, transhiatal, transthoracic, or transthoracoab-
dominal [6, 7]. Of this special anatomic location, the
disparate surgical therapeutic regimen may affect the over-
all survival. The traditional TNM classification stratified
the resectable AEG into three large groupings in terms of
the pathologic depth of invasion, the number of lymph
node metastasized, and the differentiation of the tumor.
Nevertheless, it did not focus on other clinical features,icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Demographic and clinic pathologic variables of the training and validation sets
Variable Training set Validation set
(n = 953) (n = 181)
No. of Patients Percent No. of patients Percent
Age(year)
<50 100 10.5 10 5.5
50–60 218 22.9 55 30.4
60–70 286 30.0 76 42
≥70 349 36.6 40 22.1
Sex
Male 755 79.2 157 86.7
Female 198 20.8 24 13.3
Depth of invasion
T1 203 21.3 10 5.5
T2 478 50.2 17 9.4
T3 236 24.8 152 84
T4 36 3.8 2 1.1
Lymph node metastasis (n)
0 421 44.2 53 29.3
1–2 211 22.1 42 23.2
3–6 177 18.6 40 22.1
7–15 114 12.0 40 22.1
≥15 30 3.1 6 3.3
Examined lymph node (n)
<5 116 12.2 8 4.4
5–10 211 22.1 55 30.4
10–15 206 21.6 63 34.8
15–20 173 18.2 28 15.5
20–25 109 11.4 11 6.1
25–35 97 10.2 12 6.6
35–45 23 2.4 3 1.7
≥45 18 1.9 1 0.6
Grade
G1 + G2 425 44.6 91 50.3
G3 + G4 528 55.4 90 49.7
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examined lymph node, which could be considered as the
predicting factors that affect individualized survival.
Therefore, a better evaluation system including demo-
graphic characteristics, pathological features, and treat-
ment factors is required to make more accurate survival
prediction. The nomogram is a statistics-based tool that
provides the overall probability of a specific outcome. For
many cancers, nomograms are proved to be more accurate
in predicting individualized survival when compared with
the traditional TNM staging systems [8–11]. It has beenrecently proposed as an alternative or even as a new
standard.
Although some researches have estimated the overall
survival of carcinomas of esophagus and stomach, adeno-
carcinoma of the esophagogastric junction, a newly rede-
fined individual adenocarcinoma, has not been analyzed
independently [12, 13]. The purpose of this study is to de-
velop a prognostic nomogram for patients with AEG that
are concerned by both thoracic surgeons and general sur-
geons and compare its predictive accuracy with the trad-
itional TNM staging system.
Table 2 Multivariate analysis of the training set
Variable Hazard ratio 95 % CI P value
Age(year) 1.030 1.022–1.039 <0.001
Sex
Male Ref
Female 0.849 0.672–1.073 0.170
Depth of invasion
T1 Ref
T2 1.788 1.319–2.423 <0.001
T3 1.821 1.297–2.555 0.001
T4 2.565 1.541–4.269 <0.001
Lymph node metastasis (n)
0 Ref
1–2 1.723 1.329–2.233 <0.001
3–6 2.386 1.823–3.124 <0.001
7–15 3.542 2.573–4.875 <0.001
≥15 m 6.947 4.250–11.353 <0.001
Examined lymph node (n)
<5 Ref
5–10 0.789 0.582–1.070 0.127
10–15 0.748 0.547–1.025 0.071
15–20 0.676 0.483–0.945 0.022
20–25 0.493 0.331–0.734 0.001
25–35 0.480 0.320–0.719 <0.001
35–45 0.370 0.185–0.741 0.005
≥45 0.188 0.084–0.422 <0.001
Grade
G1 + G2 Ref
G3 + G4 1.084 0.894–1.315 0.412
Fig. 1 Transformation of continuous variables in univariate analysis
using restricted cubic splines
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Patients
The Surveillance, Epidemiology, and End Results Pro-
gram (SEER) of the National Cancer Institute is an au-
thoritative source of information on cancer incidence
and survival in the USA. Data collected include patient
demographic information, pathological information, and
survival information from 1988 to 2011. The inclusion
criteria are the following: (1) patients with adenocarcin-
omas located in esophagogastric junction; (2) patients
who underwent surgery and exact pathological details
can be achieved; (3) patients without distant metastasis;
(4) Patients diagnosed after 2004 (those who can get a
more accurate pathologic data); and (5) ICD-O-3 code
within the range of 8140–8147, 8210–8214, 8220–8221,
8255, 8260–8263, 8310, and 8480–8481.
Another data set was retrospectively collected from an
Eastern medical center, The First Affiliated Hospital of
Xi’an Jiaotong University, from January 2005 to March2010. The eligibility criteria were the same as the inclusion
criteria of SEER database. The retrospectively collected
data of these patients included demographic parameters,
histopathologic tumor characteristics, operation methods,
and survival time.
Statistical analysis
We set the patients from SEER database as the training
set (n = 953) and set patients from Xi’an Jiaotong Univer-
sity as the validation set (n = 181). Categorical variables
were grouped based on the classification scheme that
clinical doctors were interested in, and the classified
groups were made before further analyses. Age, as a con-
tinuous variable, was analyzed using restricted cubic
splines by the knots of four. The results were compared
using the χ2 test or Fisher’s exact test. Continuous vari-
ables were compared using the Student t test. Survival
curves were depicted using the Kaplan-Meier method and
compared using the log-rank test. Cox proportional haz-
ard models were constructed to investigate multivariable
relationships of covariates with survival. The preselected
multiple potential interactions were tested irrespective of
significance as nomogram parameters [14]. For discrimin-
ation, we used the Harrell’s C-index to make an accurate
estimate of the nomogram system. Model validation was
performed using bootstrap to quantify our modeling strat-
egy and obtain a relatively unbiased estimate. All statistical
tests were two-sided, and P values <0.05 were considered
to be statistically significant. Statistical analyses were per-
formed using SPSS 13.0 and R software version 3.1.0
(http://www.r-project.org) with the “rms” package.
Fig. 2 Nomogram predicted 1- to 5-year overall survival using six available clinical characteristics. To use the nomogram to calculate personal
predicted survival, the patient’s age was located on the row labeled Age (year) and a straight line was drawn up to the row labeled Points to
determine the corresponding points. This process was repeated for each of the remaining factors by drawing a straight line to the “Points” row
to determine the points associated with each factor. After summarizing the total points, one located the appropriate total point number and
drawn a straight line from this to the rows labeled 1-year survival, 2-year survival, 3-year survival, 4-year survival, and 5-year survival to determine
the patient’s predicted survival probability
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Demographic and pathological characteristics of patients
For the training set, there were 953 patients who fulfilled
the inclusion criteria between 2004 and 2011. Approxi-
mately 80 % of the patients were male (n = 755) and the
rest of the 198 patients were female. The age of patients
ranged from 23 to 91 years (median was 66 years old).
There were 766 (80.4 %) patients with 7 or more lymph
nodes resected, and the average lymph nodes resection
was 15.8 (range, 1 to 90). For the validation set, 181 pa-
tients fulfilled the inclusion criteria between 2005 and
2010. More than 80 % of patients were male (n = 157)
and 13.3 % patients were female (n = 24). The age of pa-
tients ranged from 40 to 86 years (median was 64 years
old). There were 154 (85.1 %) patients with 7 or more
lymph nodes resected, and the average lymph nodes re-
section was 14.3 (range, 2 to 53). The details of patient
characteristics are listed in Table 1.Overall survival of the training set
For the 953 patients in the training set, the average
follow-up time was 25.5 months and the overall 5-year
survival rate was 38 %. For the multivariate analysis, six
clinical associated factors (age, sex, depth of invasion,
metastasized lymph nodes, examined lymph nodes,
histological grade) were evaluated regardless of the result
of univariate analysis to improve the performance of the
nomogram. The results of the multivariate analysis
(Table 2) show that age, depth of invasion, the number of
metastasized lymph nodes, and the number of exam-
ined lymph nodes were the independent prognostic fac-
tors that were significantly associated with overall survival
(P < 0.001).
Nomogram
For inclusion into the final nomogram model, effect of the
continuous variable, age was explored using restricted
Fig. 3 Kaplan-Meier survival curves of AJCC TNM stages and nomogram trisection stages of non-metastasis patients with AEG
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tivity (Fig. 1). In the nomogram model, each factor from
the multivariate Cox proportional hazard regression
model was ascribed a weighted point total that implied a
survival prognosis. For example, 65 years old was associ-
ated with 18 points, female was associated with zero point,
depth of invasion (T2) was associated with 30 points, 5
metastasized lymph nodes was associated with 44 points,
36 examined lymph nodes was associated with 39 points,
and well-differentiated adenocarcinoma was associated
with zero point, so the total score points were 167. And
each patient with a higher score had a worse prognosis.
The final nomogram model to predict the survival (1- to
5-year overall survival) of AEG patients undergoing surgi-
cal resection is shown in Fig. 2.
Prognostic discrimination was performed by dividing
the predicted survival probabilities into trisections in order
to fit the AJCC TNM staging system of non-metastasis
AEG. The results were then demonstrated with Kaplan-
Meier plotting (Fig. 3, Additional file 1: Figure S1 and
Additional file 2: Figure S2). In the training set, patients in
the lowest trisection of predicted survival had a median
recorded survival of 18.3 months, whereas those in the
middle and top trisections had median recorded survival
of 26.5 and 31.7 months, respectively. Meanwhile, themedian recorded survival of three AJCC stages were
33.3 months for stage I, 25.5 months for stage II, and
20.4 months for stage III, respectively. The nomogram
was able to stratify AEG patients into three distinct incre-
mental 5-year survival prognostic groups (trisection I with
65 %, trisection II with 37 %, trisection III with 18 %). The
5-year overall survival of three nomogram stages was sig-
nificantly different (P < 0.01). At the same time, the 5-year
survival of three AJCC stages were 61 % of stage I, 41 % of
stage II, and 24 % of stage III, respectively.
Internal and external validation of the nomogram
Predictive accuracy of the final nomogram model and
AJCC model were measured by calculating the Harrell’s
C-index. For the internal validation of the nomogram in
the training set, the C-index was 0.69 (95 % confidence
interval (CI), 0.66–0.72). It had a better discrimination
compared with the AJCC TNM staging system which had
a C-index of 0.63 (95 % CI, 0.61–0.66). Figure 4 shows the
calibration plot of the nomogram of 3- and 5-year survival
of the training set. As we could see, the predicted survival
was corresponded closely with the actual survival and was
always within the 10 % margin of error.
For the external validation of nomogram in the valid-
ation set, the C-index was 0.75 (95 % CI, 0.71–0.79).
Fig. 4 Calibration of the nomogram in the training set. Nomogram predicted probability of overall survival was plotted on the x-axis, actual
overall survival was plotted on the y-axis and 95 % CIs measured by Kaplan-Meier analysis. All predictions lie within the 10 % margin of error
(within the blue dots line). a Three-year survival. b Five-year survival
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itional AJCC TNM staging classification which had a
C-index of 0.65 (95 % CI, 0.61–0.69). Figure 5 shows
the calibration plot of the nomogram of 3- and 5-year
survival of the validation set.The relationship between nomogram and AJCC staging
system
Figure 6 provides the nomogram predicted 5-year overall
survival probability sub-grouped by AJCC TNM AEG sta-
ging scheme. As a traditional staging system, the AJCC
Fig. 5 Calibration of the nomogram in the validation set. Nomogram predicted probability of overall survival was plotted on the x-axis, actual
overall survival was plotted on the y-axis and 95 % CIs measured by Kaplan-Meier analysis. All predictions lie within the 10 % margin of error
(within the blue dots line). a Three-year survival. b Five-year survival
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vival probability. But other predictors used in our nomo-
gram model added further information that was useful to
make more accurate discrimination of the AEG patients’
prognosis. Overall, as mentioned above, the nomogram
prediction model was also able to discriminate the high-risk, moderate-risk, and low-risk patients in a grouped
survival analysis.
According to the multivariate analysis used in the nomo-
gram, three of six prognostic factors were not used in
the AJCC TNM AEG staging scheme. They were age,
sex, and the number of examined lymph nodes during
Fig. 6 Predicted 5-year overall survival probability by AJCC TNM stage. A wide range of predicted survival could be identified in each TNM stage
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these three factors, the number of examined lymph nodes
had the strongest prognostic weight. Figure 7 shows the
distribution of the number of examined lymph nodes in
different AJCC stages and nomogram stages.
Discussion
As a junctional cancer, the adenocarcinoma of esophago-
gastric junction is always riding on the wave. Its classifica-
tion, surgical approach, and the area of lymphadenectomy
are still controversial. The 7th edition of AJCC TNM clas-
sification first defined the classification of AEG. If a tumor
has an epicenter within 5 cm of the EGJ and extension
into the esophagus, it would be classified and staged ac-
cording to the esophageal scheme [5]. In previous studies,
the Siewert type I (adenocarcinoma of the distal esophagus
with the epicenter located within 1 and 5 cm above the
anatomic EGJ) AEG was staged according to the esopha-
geal scheme, while Siewert type II (adenocarcinoma of the
cardia with the tumor epicenter within 1 cm above and
2 cm below the EGJ) and type III (adenocarcinoma withthe tumor epicenter between 2 and 5 cm below the EGJ)
were staged in terms of gastric scheme. AEG might have
different biological properties compared with genuine gas-
tric cancer and genuine esophageal cancer [15]. Therefore,
further studies were required in order to ascertain if the
latest scheme is suitable or not. In our nomogram system,
the three prognostic factors (depth of invasion, metasta-
sized lymph nodes, and pathological grade) which were
also used in the AJCC staging system were assigned scores
of different scales instead of permutations and combina-
tions staging method used in AJCC staging system. Also,
we classified the metastasized lymph nodes into five sub-
groups by considering both the gastric and esophageal can-
cer schemes. Furthermore, other latent prognostic variants,
especially the number of examined lymph nodes, were
taken into account in order to assess the overall survival.
The number of total examined lymph nodes from lymph-
adenectomy and the metastatic lymph node ratio (the pro-
portion of metastasized lymph nodes of total examined
lymph nodes) were identified as significant factors that
affect the overall survival of patients with gastrointestinal
Fig. 7 The distribution of the number of examined lymph nodes in different AJCC stages and nomogram stages
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to a better overall survival and a more accurate survival
estimation [20]. For AEGs, the different surgical proce-
dures might result in different lymphadenectomy. Previ-
ous studies showed that transhiatal approach was chosen
more frequently for AEGs of early AJCC stage, while the
transthoracic approach for AEGs of advanced AJCC stage.
Meanwhile, meta-analysis indicated that more lymph
nodes were retrieved from AEGs via the transthoracic ap-
proach [21]. However, several recent studies did not
achieve all the surgical quality criteria, especially the yields
of lymphadenectomy. This might be due to particular
anatomical position of AEG. Also, it was hard to conclude
which procedure of lymphadenectomy was favorable.
Nevertheless, we found a close correlation between the
number of resected lymph nodes and overall survival. It
was our opinion that the extent of lymphadenectomy is
closely related with the overall survival of patients with
AEG. Thus, we should estimate the personal survival of
AEG patients in consideration of the total examinedlymph nodes. This not only requires our surgeons to per-
form an adequate lymphadenectomy but also demands
the pathologists to do their best in searching for lymph
nodes.
After the combination of two more demographic char-
acteristics (age and sex) with the four clinic factors (in-
vasion depth, examined lymph nodes, metastatic lymph
nodes and histological grade), the six factors calculated
in nomogram had made a more accurate personal over-
all survival estimation of AEG patients. The prognostic
nomogram directly quantified patient risk based on the
variant prognostic factors without forming risk groups
which was more favorable than the AJCC TNM classifica-
tion estimated by C-index [22]. As we could see from Fig. 6,
three AJCC TNM groups produced almost the same range
of nomogram predicted survival. This indicated that the
traditional AJCC classification might cause some bias
when we predicted the personal overall survival. One study
from Memorial Sloan Kettering Cancer Center (MSKCC)
developed a postoperative nomogram for disease specific
Zhou et al. World Journal of Surgical Oncology  (2015) 13:197 Page 10 of 10survival after curative surgery. But they mixed the AEG
data with the gastric adenocarcinomas [23]. This would re-
sult in some inaccurate estimation of AEG. Meanwhile, an-
other study from Netherlands calculated the nomogram
score of patients with Siewert type I and type II [24]. Also,
these two well-constructed nomogram scoring system
were all from Western countries. It was uncertain whether
they could be used to predict patients’ outcome of the East
Asian countries. In our study, we used the data from SEER
database which was constituted of patients most from
Western countries to establish the training dataset and we
used the patients from China to validate the nomogram
scores generated from the training set. The result mani-
fested that the two datasets displayed equal effectiveness in
predicting personal overall survival.
Conclusions
We developed and externally validated a nomogram pre-
dicting overall survival of AEG patients based on a West-
ern and an Eastern database. The nomogram provided
significantly better discrimination than the traditional
AJCC TNM classification of AEGs and also provided an
individualized prediction of the survival.
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